Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors

Journal: Nature Communications

Published: 2019-12-06

DOI: 10.1038/s41467-019-13348-2

Affiliations: 15

Authors: 24

Go to article
Institutions Share
Research Center for Molecular Mechanisms of Aging and Age-Related Diseases, MIPT, Russia 0.37
Department of Pharmacology-Physiology, USherbrooke, Canada 0.08
Pharmacology Institute of Sherbrooke (IPS), USherbrooke, Canada 0.08
Ono Pharmaceutical Co., Ltd., Japan 0.08
USC Bridge Institute, United States of America (USA) 0.07
USC Michelson Center for Convergent Bioscience, United States of America (USA) 0.07
USC Department of Chemistry, United States of America (USA) 0.06
USC Department of Biological Sciences, United States of America (USA) 0.03
Division Structural Biochemistry (ICS-6), FZJ, Germany 0.03
JuStruct: Jülich Centre for Structural Biology, FZJ, Germany 0.03
Skoltech Center for Computational and Data-Intensive Science and Engineering (CDISE), Russia 0.02
Research Center for Molecular Medicine (CeMM), ÖAW, Austria 0.02
Institute for Structural Biology (IBS), France 0.02
Institute of Crystallography (IFK), RWTH Aachen, Germany 0.02
Merck Research Laboratories (MRL) - West Point, United States of America (USA) 0.01

Return

Except where otherwise noted © 2020 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER